PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsstatus epilepticus
MeSH D013226 - status epilepticus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012640:Seizures
$
Success rate
D013226: 
Status epilepticus
$
Success rate
D017036:Epilepsia partialis continua
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDiazepam Diazepam  1985-11-01   
Pentobarbital Pentobarbital  1982-01-01   
Propofol Propofol  2000-09-19   
PadagisMidazolam Midazolam  2005-05-02   
Taro PharmaceuticalPhenytoin Extended Phenytoin  2006-09-05   
Phenytoin Phenytoin  2004-03-08   
MylanDiazepam Diazepam  1985-09-04   
Fosphenytoin Fosphenytoin  2010-06-08   
Phenytoin Phenytek  1998-12-28   
PerrigoPentobarbital Pentobarbital  1982-01-01   
RocheDiazepam Valium  1982-01-01   
Diazepam Valrelease  1982-01-01   
Midazolam Versed  1998-10-15   
Lupin ResearchPhenytoin Extended Phenytoin  2019-09-30   
Lorazepam Lorazepam  2013-02-19   
Fosphenytoin Sesquient 2029-03-13 2020-11-05   
SandozLorazepam Lorazepam  1987-04-21   
WyethPentobarbital Pentobarbital  1982-01-01   
UCBMidazolam Nayzilam 2028-01-18 2019-05-17   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
75%
9/12
Phase 3
52%
14/27
Approved: 9Overall Success rate: 39%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Roche
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use